LOW-DOSE LENALIDOMIDE IN ADDITION TO LOW-DOSE CYTARABINE INDUCES LONG-LASTING COMPLETE REMISSIONS IN A SUBSTANTIAL PROPORTION OF VERY ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS WITH UNFAVORABLE KARYOTYPE

被引：0
|
作者：
Visani, G. [1 ]
Ferrara, F. [2 ]
Di Raimondo, F. [3 ]
Caraci, M. [3 ]
Izzo, T. [2 ]
Riccardi, C. [2 ]
Barulli, S. [1 ]
Guiducci, B. [1 ]
Loscocco, F. [1 ]
Ricciardi, T. [1 ]
Sparaventi, G. [1 ]
Isidori, A. [1 ]
机构：
[1] Hematol & Stem Cell Transplant Ctr, Pesaro, Italy
[2] Cardarelli Hosp, Hematol, Naples, Italy
[3] Catania Univ, Hematol, Catania, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0057
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia
    Chen, Chen
    Xu, Wei
    Yang, Jing
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 141 - 146
  • [42] Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia
    Suzushima, Hitoshi
    Wada, Naoko
    Yamasaki, Hiroshi
    Eto, Kenichiro
    Shimomura, Taizo
    Kugimiya, Michiko H.
    Horikawa, Kentaro
    Nishimura, Shintaro
    Tsuda, Hiroyuki
    Mitsuya, Hiroaki
    Asou, Norio
    LEUKEMIA RESEARCH, 2010, 34 (05) : 610 - 614
  • [43] EFFECTIVENESS OF TREATMENT ACUTE MYELOID LEUKEMIA IN THE ELDERLY USING CLADRIBINE WITH LOW-DOSE ARAC
    Watek, M.
    Gromek, T.
    Pluta, A.
    Budziszewska, K.
    Majowicz, D.
    Sierlecka, E.
    Hus, M.
    Pasiarski, M.
    Gozdz, S.
    Wierzbowska, A.
    HAEMATOLOGICA, 2017, 102 : 378 - 378
  • [44] Frontline Therapy for Older Patients (pts) with Acute Myeloid Leukemia (AML): Clofarabine Plus Low-Dose Cytarabine Induction Followed by Prolonged Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with Decitabine
    Faderl, Stefan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Huang, Xuelin
    Jabbour, Elias
    Kadia, Tapan
    Ferrajoli, Alessandra
    Estrov, Zeev
    Feliu, Jennie
    Schroeder, Heather
    Kwari, Monica
    Kantarjian, Hagop
    BLOOD, 2010, 116 (21) : 152 - 152
  • [45] A Randomised Evaluation of Low-Dose Cytarabine Arabinoside Plus Lenalidomide Versus Single-Agent Low-Dose Cytarabine Arabinoside in Older Patients with Acute Myeloid Leukaemia: Results from the LI-1 Trial
    Coplan, Mhairi
    Ariti, Cono
    Thomas, Ian
    Upton, Laura
    Sydenham, Mia
    Mehta, Priyanka
    Islam, Shahidul
    Kjeldsen, Lars
    Burnett, Alan K.
    Hills, Robert
    Russell, Nigel H.
    Dennis, Mike
    BLOOD, 2021, 138
  • [46] LONG-TERM REMISSION OF ACUTE MYELOID-LEUKEMIA WITH TRILINEAGE MYELODYSPLASIA TREATED SOLELY WITH LOW-DOSE CYTARABINE
    JACK, FR
    SUMMERFIELD, GP
    CLINICAL AND LABORATORY HAEMATOLOGY, 1994, 16 (02): : 197 - 200
  • [47] The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study
    Wrzesien-Kus, A
    Robak, T
    Jamroziak, K
    Wierzbowska, A
    Dmoszynska, A
    Adamczyk-Cioch, M
    Kuliczkowski, K
    Mazur, G
    Holowiecki, J
    Konopka, L
    Maj, S
    Marianska, B
    Zawilska, K
    NEOPLASMA, 2002, 49 (06) : 405 - 411
  • [48] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
    Ferrara, Felicetto
    BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [49] Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report
    Liu, Bingshan
    Narurkar, Roshni
    Hanmantgad, Madhura
    Zafar, Wahib
    Song, Yongping
    Liu, Delong
    FRONTIERS OF MEDICINE, 2018, 12 (05) : 593 - 599
  • [50] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
    Felicetto Ferrara
    Blood Cancer Journal, 10
12345